How Recreational Pot Is Hurting Medical Marijuana Patients in California

Recreational marijuana is bringing in millions of tax dollars for the state of California, but there are also some downsides. Greg Zeman, associate editor at Cannabis Now, explains how the state's new laws are hurting some medical marijuana patients. Some medical marijuana companies donate products to non-profits like the Weed For Warriors Project, which gives medical marijuana patients free pot. Due to the state's new tax regulations on weed, companies still have to pay taxes on these donations. 100 pounds of cannabis would cost roughly $50,000 in taxes. Regulations across the country are holding American businesses back from competing with Canada, according to Zeman. He says Canadian companies are gearing up to take over global pot markets as more countries legalize recreational marijuana. California is the largest producer of cannabis, but federal regulations prevent it from selling to global markets.

More In Business

AI Is Moving from Hype to Business: Here’s Where the Real Money Could Be

Steve Lucas, Chairman and CEO of Boomi, explains why enterprise data, integration and governance could unlock AI’s next wave of growth and ROI.

NVIDIA Is Forecasting 70% Growth, Is Wall Street Ready for What’s Next?

Dan Niles, Founder and Portfolio Manager at Niles Investment Management, breaks down NVIDIA’s blowout earnings, 70% growth forecast and AI spending boom.

Forget Cutting the Grass: These Solar-Powered Robots Are Taking Over Lawns

Edwin Cywinski, CEO of SunScout Holding Limited, explains how solar-powered robotic mowers are transforming lawn care and the company’s plans to scale.

NVIDIA Chips Are Becoming Wall Street’s New Favorite Asset: Here’s Why

Nathan Bomey, Business Reporter at Axios and author of The Axios Closer newsletter, explains why Wall Street is turning NVIDIA’s AI chips into financial assets.

Ring Unveils a New Way to Protect Your Home Security Footage

Jamie Siminoff, Founder and Chief Inventor of Ring, explains the company’s new TAKE encryption standard and its push to put privacy and video data control first

From COVID To Cancer: How Far Can Moderna Take mRNA Technology?

Xavier Martinez, News Associate at The Wall Street Journal, breaks down Moderna’s mRNA ambitions, its pipeline beyond COVID-19 and the challenges ahead.

Anthropic, OpenAI and SpaceX: Inside the Battle for Sky-High Valuations

Al Root, Business Reporter at Barron’s, breaks down Anthropic’s potential IPO, rapid growth and how it stacks up against OpenAI and SpaceX.

Back-To-School Shopping Is Getting Expensive: Here’s How Parents Can Save

Trae Bodge, Smart Shopping Expert at Truetrae.com, shares how parents can save money, spot real deals and shop smarter this back-to-school season.

AI Is Changing the M&A Game: Companies Are Rethinking Big Deals

Dena Jalbert, CEO of Align Advisory Services, breaks down the M&A outlook for 2026 as AI costs, debt, valuations and economic uncertainty reshape deal-making.

The Consumer Is Splitting in Two: What Retail Earnings Reveal About Who’s Still Spending

LSEG Consumer Research Director Jharonne Martis breaks down retail earnings, the K-shaped consumer and what inflation and rising costs mean for spending.

Load More